Abstract
Selective upper airway stimulation (UAS) is a novel therapy for patients with obstructive sleep apnea (OSA). The aim of this study was to analyze the application and outcome of UAS in patients with moderate to severe OSA in the clinical routine of a tertiary referral center. The design of this study is single-center, prospective clinical trial. Thirty-one patients who received a UAS device (Inspire Medical Systems) were included. Treatment outcome was evaluated at 2, 3, 6, and 12 months after surgery. Data collection included demographics, body mass index (BMI), apnea hypopnea index (AHI), oxygen saturation and desaturation index (ODI), Epworth Sleepiness Score (ESS), adverse events, and adherence to therapy. Sher criteria were used to evaluate treatment response. The mean age was 59.6 years with thirty patients being male. Mean BMI was 28.8 kg/m2. The mean pre-implantation AHI of 32.9/h could be reduced to 7.1/h after 12 months (p < 0.001). The mean pre-implantation ODI of 30.7/h could be reduced to 9.9/h after 12 months (p = 0.004). The mean pre-implantation ESS of 12.6 could be reduced to 5.9 after 12 months (p = 0.006). Serious adverse events did not occur. Therapy adherence was a usage of 6.6 h/night after 12 months. OSA severity and subjective daytime sleepiness were improved in patients with moderate to severe OSA after receiving UAS therapy. Patients maintained high adherence to therapy use after 12 months. It is encouraging that UAS has been shown to be successfully implemented in the routine clinical management of OSA outside of a clinical trial setting.
Similar content being viewed by others
References
Strollo PJ, Rogers RM (1996) Obstructive sleep apnea. N Engl J Med 334(2):99–104
Pengo MF, Steier J (2015) Emerging technology: electrical stimulation in obstructive sleep apnoea. J Thorac Dis 7(8):1286–1297
Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235
Peppard PE, Young T, Barnet JH et al (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006–1014
Steier J, Martin A, Harris J et al (2014) Predicted relative prevalence estimates for obstructive sleep apnoea and the associated healthcare provision across the UK. Thorax 69(4):390–392
Narkiewicz K, Somers VK (1999) Obstructive sleep apnea as a cause of neurogenic hypertension. Curr Hypertens Rep 1(3):268–273
Martinez D, Klein C, Rahmeier L et al (2012) Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep Breath 16(3):695–701
Palomäki H, Partinen M, Juvela S et al (1989) Snoring as a risk factor for sleep-related brain infarction. Stroke 20(10):1311–1315
Bradley TD, Rutherford R, Grossman RF et al (1985) Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131(6):835–839
Lévy P, Bonsignore MR, Eckel J (2009) Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 34(1):243–260
Punjabi NM, Sorkin JD, Katzel LI et al (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165(5):677–682
Sawyer AM, Gooneratne NS, Marcus CL et al (2011) A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 15(6):343–356
McArdle N, Devereux G, Heidarnejad H et al (1999) Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159(4 Pt 1):1108–1114
Stuck BA, Leitzbach S, Maurer JT (2012) Effects of continuous positive airway pressure on apnea-hypopnea index in obstructive sleep apnea based on long-term compliance. Sleep Breath 16(2):467–471
Caples SM, Rowley JA, Prinsell JR et al (2010) Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep 33(10):1396–1407
Heiser C, Maurer JTSteffen A (2015) Functional outcome of tongue motions with selective hypoglossal nerve stimulation in patients with obstructive sleep apnea. Sleep Breath 20(2):553–560
Hofauer B, Strohl K, Knopf A et al (2016) Sonographic evaluation of tongue motions during upper airway stimulation for obstructive sleep apnea-a pilot study. Sleep Breath (Epub ahead of print)
Strollo PJ, Soose RJ, Maurer JT et al (2014) Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 370(2):139–149
Kezirian EJ, Hohenhorst Wde Vries N (2011) Drug-induced sleep endoscopy: the VOTE classification. Eur Arch Otorhinolaryngol 268(8):1233–1236
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
Van de Heyning PH, Badr MS, Baskin JZ et al (2012) Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope 122(7):1626–1633
Heiser C, Hofauer B, Lozier L et al (2016) Nerve monitoring guided selective hypoglossal nerve stimulation in obstructive sleep apnea. Laryngoscope. doi:10.1002/lary.26026
Heiser C, Thaler E, Boon M et al. (2016) Updates of operative techniques for upper airway stimulation. Laryngoscope Suppl 7:S12–S16
Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8(5):597–619
Sher AE, Schechtman KB, Piccirillo JF (1996) The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 19(2):156–177
Woodson BT, Gillespie MB, Soose RJ et al (2014) Randomized controlled withdrawal study of upper airway stimulation on OSA: short- and long-term effect. Otolaryngol Head Neck Surg 151(5):880–887
Strollo PJ, Gillespie MB, Soose RJ et al (2015) Upper airway stimulation for obstructive sleep apnea: durability of the treatment effect at 18 months. Sleep 38(10):1593–1598
Soose RJ, Woodson BT, Gillespie MB et al (2016) Upper airway stimulation for obstructive sleep apnea: self-reported outcomes at 24 months. J Clin Sleep Med 12(1):43–48
Woodson BT, Soose RJ, Gillespie MB et al (2016) Three-year outcomes of cranial nerve stimulation for obstructive sleep apnea: the STAR trial. Otolaryngol Head Neck Surg 154(1):181–188
Kent DT, Lee JJ, Strollo PJ et al. (2016) Upper airway stimulation for OSA: early adherence and outcome results of one center. Otolaryngol Head Neck Surg 55(1):188–193
Sommer UJ, Heiser C, Gahleitner C et al (2016) Tonsillectomy with uvulopalatopharyngoplasty in obstructive sleep apnea. Dtsch Arztebl Int 113(1–02):1–8
Friedman M, Jacobowitz O, Hwang MS et al. (2016) Targeted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea: six-month results. Laryngoscope. doi:10.1002/lary.25909
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Clemens Heiser is a study investigator and consultant of Inspire Medical System and received personal fees, travel expenses, and research grants. Andreas Knopf, Murat Bas, Constanze Gahleitner, and Benedikt Hofauer have no conflict of interest.
The presented study did not involve animal experiments. Informed consent was obtained from each patient. The study was approved by the local ethics committee (Fakultät für Medizin, Ethikkommission, Technische Universität München, Germany).
Rights and permissions
About this article
Cite this article
Heiser, C., Knopf, A., Bas, M. et al. Selective upper airway stimulation for obstructive sleep apnea: a single center clinical experience. Eur Arch Otorhinolaryngol 274, 1727–1734 (2017). https://doi.org/10.1007/s00405-016-4297-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-016-4297-6